AXIM BIOTECHNOLOGIES, INC. (AXIM) Shareholders’ equity 2014–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) shareholders’ equity at each fiscal year-end, per SEC filings.
-$7.7MFY2023 · since FY2014: -$580,723 → -$7.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$7.7M | -58.7% |
| FY2022 | -$4.8M | -106.4% |
| FY2021 | -$2.3M | -249.3% |
| FY2020 | $1.6M | +123.2% |
| FY2019 | -$6.8M | -11.2% |
| FY2018 | -$6.1M | +3.2% |
| FY2017 | -$6.3M | -165.0% |
| FY2016 | -$2.4M | -39.9% |
| FY2015 | -$1.7M | -191.9% |
| FY2014 | -$580,723 | — |
Source: SEC XBRL filings · For reference only · Not investment advice